Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells
- PMID: 17487250
- DOI: 10.1139/Y06-101
Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells
Abstract
Transactivation of epidermal growth factor receptor (EGFR) is a well-documented mechanism by which vasoactive peptides and H2O2 elicit their cellular responses. However, a role for the insulin-like growth factor type-1 receptor (IGF-1R) transactivation in mediating the effects of angiotensin II (Ang II) and H2O2 in vascular smooth muscle cells from different artery types have also been recently recognized. By using a series of pharmacological inhibitors of various growth factor receptor tyrosine kinases and a direct analysis of the phosphorylation status of the beta-subunit of IGF-1R, a requirement of this growth factor receptor in Ang II and H2O2 response has been demonstrated. This review discusses some of the studies that highlight the importance of IGF-1R transactivation in mediating Ang II- and H2O2-induced mitogen-activated protein kinase and protein kinase B signaling pathways.
Similar articles
-
Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.Can J Physiol Pharmacol. 2009 Dec;87(12):1009-18. doi: 10.1139/Y09-056. Can J Physiol Pharmacol. 2009. PMID: 20029537
-
Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.Can J Physiol Pharmacol. 2006 Jul;84(7):777-86. doi: 10.1139/y06-024. Can J Physiol Pharmacol. 2006. PMID: 16998541
-
Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.Can J Physiol Pharmacol. 2003 Feb;81(2):159-67. doi: 10.1139/y02-164. Can J Physiol Pharmacol. 2003. PMID: 12710530
-
Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells.Can J Physiol Pharmacol. 2010 May;88(5):501-9. doi: 10.1139/y10-030. Can J Physiol Pharmacol. 2010. PMID: 20555420 Review.
-
Ca2+/calmodulin-dependent protein kinase- II in vasoactive peptide- induced responses and vascular biology.Curr Vasc Pharmacol. 2014 Mar;12(2):249-57. doi: 10.2174/1570161112666140226123139. Curr Vasc Pharmacol. 2014. PMID: 24568154 Review.
Cited by
-
Age-related changes in redox signaling and VSMC function.Antioxid Redox Signal. 2010 Mar 1;12(5):641-55. doi: 10.1089/ars.2009.2854. Antioxid Redox Signal. 2010. PMID: 19737090 Free PMC article. Review.
-
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.Front Pharmacol. 2018 Jan 11;8:970. doi: 10.3389/fphar.2017.00970. eCollection 2017. Front Pharmacol. 2018. PMID: 29375377 Free PMC article.
-
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.J Cell Physiol. 2008 Nov;217(2):377-87. doi: 10.1002/jcp.21507. J Cell Physiol. 2008. PMID: 18615585 Free PMC article.
-
Deficiency of insulin-like growth factor-1 receptor confers resistance to oxidative stress in C2C12 myoblasts.PLoS One. 2013 May 10;8(5):e63838. doi: 10.1371/journal.pone.0063838. Print 2013. PLoS One. 2013. PMID: 23675509 Free PMC article.
-
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Mediators Inflamm. 2010;2010:174341. doi: 10.1155/2010/174341. Epub 2010 Jun 28. Mediators Inflamm. 2010. PMID: 20652043 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous